Electrochemical monitoring of an important biomarker and target protein: VEGFR2 in cell lysates

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Wei, Tianxiang ^a   Tu, Wenwen ^a   Zhao, Bo ^a   Lan, Yaqian ^a   Bao, Jianchun ^a   Dai, Zhihui ^a  

^a NANJING NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBANILAMIDE DERIVATIVE; CHITOSAN; GRAPHITE; N-(4-BROMO-2-FLUOROPHENYL)-6-METHOXY-7-((1-METHYLPIPERIDIN-4-YL)METHOXY)QUINAZOLIN-4-AMINE; NICOTINAMIDE; PHENOTHIAZINE DERIVATIVE; PIPERIDINE DERIVATIVE; PROTEIN KINASE INHIBITOR; QUINAZOLINE DERIVATIVE; SORAFENIB; THIONINE; VASCULOTROPIN RECEPTOR 2;

ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; ELECTROCHEMICAL ANALYSIS; ENDOTHELIUM CELL; GENETIC PROCEDURES; IMMUNOASSAY; METABOLISM; OXIDATION REDUCTION REACTION; PROCEDURES; RETINA; RHESUS MONKEY;

ANIMALS; BIOSENSING TECHNIQUES; CELL LINE; CHITOSAN; ELECTROCHEMICAL TECHNIQUES; ENDOTHELIAL CELLS; GRAPHITE; IMMUNOASSAY; MACACA MULATTA; NIACINAMIDE; OXIDATION-REDUCTION; PHENOTHIAZINES; PHENYLUREA COMPOUNDS; PIPERIDINES; PROTEIN KINASE INHIBITORS; QUINAZOLINES; RETINA; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84893872358     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03982     Document Type: Article

References (39)

1. Tugues, S., Koch, S., Gualandi, L., Li, X. J. & Claesson-Welsh, L. Vascular endothelial growth factors and receptors: Anti-Angiogenic therapy in the treatment of cancer. Mol. Asp. Med. 32, 88-111 (2011)
2. Ferrara, N. & Kerbel, R. S. Angiogenesis as a therapeutic target. Nature 438, 967-974 (2005) (Pubitemid 43093963)
3. Freeman, R. et al. Optical aptasensors for the analysis of the vascular endothelial growth factor (VEGF) Anal. Chem. 84, 6192-6198 (2012)
4. Lee, S. et al. Autocrine VEGF signaling is required for vascular homeostasis. Cell 130, 691-703 (2007) (Pubitemid 47268059)
5. Steeg, P. S. Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med. 12, 895-904 (2006) (Pubitemid 44175140)
6. Kalishwaralal, K., BarathManiKanth, S., Pandian, S. R. K., Deepak, V. & Gurunathan, S. Silver nano-A trove for retinal therapies. J. Control. Release 145, 76-90 (2010)
7. Ferrajoli, A. et al. High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia. Clin. Cancer Res. 7, 795-799 (2001) (Pubitemid 32708712)
8. Fabris, L. et al. Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases. Hepatology 43, 1001-1012 (2006) (Pubitemid 43724625)
9. Spannuth, W. A. et al. Functional significance of VEGFR-2 on ovarian cancer cells. Int. J. Cancer 124, 1045-1053 (2009)
10. Taylor, M. et al. High levels of circulating VEGFR21 bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies Clin. Cancer Res. 15, 4561-4571 (2009)
11. Liu, D. H., Liu, F. X., Liu, Z. H., Wang, L. L. & Zhang, N. Tumor specific delivery and therapy by double-targeted nanostructured lipid carriers with anti-VEGFR-2 antibody. Mol. Pharm. 8, 2291-2301 (2011)
12. Pajares, M. J. et al. Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung. J. Clin. Oncol. 30, 1129-1136 (2012)
13. Birkhahn, M. et al. Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles. Eur. Urol. 57, 12-20 (2010)
14. Mitra, A. P. & Cote, R. J. Molecular pathogenesis and diagnostics of bladder cancer. Annu. Rev. Pathol.-Mech Dis. 4, 251-285 (2009)
15. Youssoufian, H., Hicklin, D. J. & Rowinsky, E. K. Review:Monoclonal Antibodies to the Vascular Endothelial Growth Factor Receptor-2 in Cancer Therapy. Clin. Cancer Res. 13, 5544s-5548s (2007) (Pubitemid 47510385)
16. Ivy, S. P.,Wick, J. Y. & Kaufman, B. M. An overview of small-molecule inhibitors of VEGFR signaling. Nat. Rev. Clin. Oncol. 6, 569-579 (2009)
17. Dev, I. K. et al. Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models. Br. J. Cancer 91, 1391-1398 (2004) (Pubitemid 39424803)
18. Meissner, M. et al.Down-regulation of vascular endothelial growth factor receptor 2 is a major molecular determinant of proteasome inhibitor-mediated antiangiogenic action in endothelial cells. Cancer Res. 69, 1976-1984 (2009)
19. Benedito, R. et al. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling. Nature 484, 110-114 (2012)
20. Nacev, B. A., Grassi, P., Dell, A., Haslam, S. M. & Liu, J. O. The antifungal drug itraconazole inhibits vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, trafficking, and signaling in endothelial cells. J. Biol. Chem. 286, 44045-44056 (2011)
21. Ji, Z. et al. 3-Amino-benzo[d]isoxazoles as novel multitargeted inhibitors of receptor tyrosine kinases. J. Med. Chem. 51, 1231-1241 (2008) (Pubitemid 351480385)
22. Tong, S., Ren, B. B., Zheng, Z. L., Shen, H. & Bao, G. Tiny grains give huge gains: nanocrystal-based signal amplification for biomolecule detection. ACS Nano 7, 5142-5150 (2013)
23. Lou, X. H., Zhao, T., Liu, R., Ma, J. & Xiao, Y. Self-Assembled DNA monolayer buffered dynamic ranges of mercuric electrochemical sensor. Anal. Chem. 85, 7574-7580 (2013)
24. Han, C. et al. A multiwalled-carbon-nanotube-based biosensor for monitoring microcystin-LR in sources of drinking water supplies. Adv. Funct. Mater. 23, 1807-1816 (2013)
25. Chai, X. L. et al. A two-channel ratiometric electrochemical biosensor for in vivo monitoring of copper ions in a rat brain using gold truncated octahedral microcages. Angew. Chem. 125, 8287-8291 (2013)
26. Wen, Y. L. et al. DNA Nanostructure-based Interfacial engineering for PCR-free ultrasensitive electrochemical analysis of microRNA. Sci. Rep. 2, 867 (2013)
27. Deng, W. P. Diagnosis of schistosomiasis japonica with interfacial co-Assemblybasedmulti- channel electrochemical immunosensor arrays. Sci. Rep. 3, 1789 (2013)
28. Martic, S., Labib, M., Freeman, D. & Kraatz, H. B. Probing the role of the linker in ferrocene-ATP conjugates monitoring protein kinase catalyzed phosphorylations electrochemically. Chem. Eur. J. 17, 6744-6752 (2011)
29. Huang, Y. X., Cai, D. & Chen, P. Micro- and nanotechnologies for study of cell secretion. Anal. Chem. 83, 4393-4406 (2011)
30. Chen, D., Feng, H. B. & Li, J. H. Graphene oxide: preparation, functionalization, and electrochemical applications. Chem. Rev. 112, 6027-6053 (2012)
31. McTigue, M. et al. Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors. Proc. Natl. Acad. Sci. U. S. A. 109, 18281-18289 (2012)
32. Zhang, J. L. et al. Reduction of graphene oxidevia L-Ascorbic acid. Chem. Commun. 46, 1112-1114 (2010)
33. Li, D., Muller, M. B., Gilje, S., Kaner, R. B. &Wallace, G. G. Processable aqueous dispersions of graphene nanosheets. Nat. Nanotechnol. 3, 101-105 (2008) (Pubitemid 351225404)
34. Stankovich, S. et al. Synthesis of graphene-based nanosheets via chemical reduction of exfoliated graphite oxide. Carbon 45, 1558-1565 (2007) (Pubitemid 46829016)
35. Guo, H. L., Wang, X. F., Qian, Q. Y.,Wang, F. B. & Xia, X. H. A green approach to the synthesis of graphene nanosheets. ACS Nano 3, 2653-2659 (2009)
36. Fang, M., Long, L. A., Zhao, W. F., Wang, L. W. & Chen, G. H. pH-responsive chitosan-mediated graphene dispersions. Langmuir 26, 16771-16774 (2010)
37. Du, D. et al. Functionalized graphene oxide as a nanocarrier in a multienzyme labeling amplification strategy for ultrasensitive electrochemical immunoassay of phosphorylated p53 (S392) Anal. Chem. 83, 746-752 (2011)
38. Yang, M. H., Yang, Y. H., Yang, Y., Shen, G. L. & Yu, R. Q. Bienzymatic amperometric biosensor for choline based on mediator thionine in situ electropolymerized within a carbon paste electrode. Anal. Biochem. 334, 127-134 (2004) (Pubitemid 39304083)
39. Adya, R., Tan, B. K., Punn, A., Chen, J. & Randeva, H. S. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. Cardiovasc. Res. 78, 356-365 (2008) (Pubitemid 351556097)